Skip to main content
. 2021 May 5;10(5):725. doi: 10.3390/antiox10050725

Table 3.

Various formulations prepared for identifying and screening the highest and lowest concentrations of independent variables.

No. Surfactant/Co-Solvent Type Drug
(%)
Manual Observation
A B C D
F1 8.9 - - - 0.6 Settling of curcumin on keeping overnight.
Crystals of curcumin seen in microscope.
F2 8.9 5 - - 0.6 Settling of curcumin on keeping overnight.
Crystals of curcumin seen in microscope.
F3 8.9 8 - - 0.6 No settling of curcumin but crystals of curcumin were seen under microscope.
F4 8.9 - 5 - 0.6 Settling of curcumin observed.
F5 8.9 - 8 - 0.6 No settling of curcumin but crystals of curcumin were seen under the microscope. Gelucire was expelled out.
F6 8.9 5 5 - 0.6 No settling of curcumin but crystals of curcumin were seen under the microscope. Gelucire was expelled out.
F7 8.9 5 8 - 0.6 No settling of curcumin but crystals of curcumin were seen under microscope. Gelucire was expelled out.
F8 8.9 - - 5 0.6 Settling of curcumin observed.
F9 8.9 - - 8 0.6 Settling of curcumin observed.
F10 8.9 5 8 0.6 Crystals of curcumin observed under the microscope.
F11 8.9 5 10 0.6 Crystals of curcumin observed under the microscope.
F12 8.9 8 10 0.6 Crystals of curcumin were not observed under the microscope.
F13 12 5 - - 0.6 Crystals of curcumin observed under the microscope.
F14 12 8 - - 0.6 Crystals of curcumin were observed under the microscope.
F15 12 - - 5 0.6 Crystals of curcumin observed under the microscope.
F16 12 - - 8 0.6 Crystals were not observed under microscope until 4 weeks.

A = Tween 80, B = PEG 400, C = Gelucire14/44, D = PEG 600.